title: Efficacy of anakinra in a case of refractory Still disease.
authors.affiliation: CHRU de Tours, Service de Médecine Interne, Tours, France. debiais@med.univ-tours.fr
authors.forename: Severine
authors.initials: S
authors.lastname: Debiais
authors.forename: Francois
authors.initials: F
authors.lastname: Maillot
authors.forename: Luminita
authors.initials: L
authors.lastname: Luca
authors.forename: Jennifer
authors.initials: J
authors.lastname: Buret
authors.forename: Bruno
authors.initials: B
authors.lastname: Fautrel
authors.forename: Jean Paul
authors.initials: JP
authors.lastname: Renard
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects / Q000627:therapeutic use*; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein